NZ592861A - Pharmaceutical aerosol composition - Google Patents

Pharmaceutical aerosol composition

Info

Publication number
NZ592861A
NZ592861A NZ592861A NZ59286109A NZ592861A NZ 592861 A NZ592861 A NZ 592861A NZ 592861 A NZ592861 A NZ 592861A NZ 59286109 A NZ59286109 A NZ 59286109A NZ 592861 A NZ592861 A NZ 592861A
Authority
NZ
New Zealand
Prior art keywords
adjuvant
residue
aerosol composition
solution
pharmaceutical aerosol
Prior art date
Application number
NZ592861A
Other languages
English (en)
Inventor
Amar Lulla
Geena Malhotra
Rajendra Narayanrao Kankan
Dharmaraj Ramachandra Rao
Maruti Ghagare
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2009/002575 external-priority patent/WO2010052450A1/en
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of NZ592861A publication Critical patent/NZ592861A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ592861A 2008-11-04 2009-11-04 Pharmaceutical aerosol composition NZ592861A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN2351MU2008 2008-11-04
IN2402MU2008 2008-11-14
PCT/GB2009/002575 WO2010052450A1 (en) 2008-11-04 2009-10-29 Tiotropium bromide having a low degree of crystallinity
PCT/GB2009/002617 WO2010052466A2 (en) 2008-11-04 2009-11-04 Pharmaceutical aerosol composition

Publications (1)

Publication Number Publication Date
NZ592861A true NZ592861A (en) 2013-01-25

Family

ID=41630445

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ592861A NZ592861A (en) 2008-11-04 2009-11-04 Pharmaceutical aerosol composition

Country Status (12)

Country Link
EP (1) EP2362766A2 (xx)
JP (1) JP2012507574A (xx)
KR (1) KR20110096538A (xx)
CN (1) CN102238939B (xx)
AU (1) AU2009312598A1 (xx)
BR (1) BRPI0916047A2 (xx)
CA (1) CA2742718A1 (xx)
MX (1) MX2011004730A (xx)
NZ (1) NZ592861A (xx)
RU (1) RU2565438C2 (xx)
WO (1) WO2010052466A2 (xx)
ZA (1) ZA201103347B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
CA2885767A1 (en) * 2012-10-23 2014-05-01 Cipla Limited Pharmaceutical composition
GB201306984D0 (en) * 2013-04-17 2013-05-29 Mexichem Amanco Holding Sa Composition
KR101484481B1 (ko) * 2014-08-07 2015-01-20 주식회사 다림바이오텍 Pde-5 저해제를 포함하는 설하분무제의 제조방법 및 이에 의하여 제조된 설하분무용 조성물
CN107320464A (zh) * 2017-04-28 2017-11-07 北京北朋科技有限公司 高ph值的布地奈德混悬液的制备方法
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
EP3860580A4 (en) * 2018-10-01 2022-07-20 Kindeva Drug Delivery L.P. FORMULATION AND AEROSOL CANS, INHALERS AND LIKE WITH THE FORMULATION
CN114796166A (zh) * 2021-01-29 2022-07-29 北京远大九和药业有限公司 一种含有萜烯类挥发油的气雾剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684698A (en) * 1986-05-02 1987-08-04 Gaf Corporation Water soluble multicomplex of chlorothiazide, furosemide and poly(N-vinyl-2-pyrrolidone)
IL103238A (en) * 1991-09-25 1995-07-31 Fisons Plc Pressed aerosol preparations
EP0655237A1 (de) * 1993-11-27 1995-05-31 Hoechst Aktiengesellschaft Medizinische Aerosolformulierung
CN1137680C (zh) * 1995-09-19 2004-02-11 藤泽药品工业株式会社 气雾剂组合物
ATE239447T1 (de) * 1997-09-29 2003-05-15 Inhale Therapeutic Syst In verneblern verwendbare, stabilisierte zubereitungen
DE10214031A1 (de) * 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
RS20060291A (xx) * 2003-11-03 2008-06-05 Boehringer Ingelheim International Gmbh., Novi kristalni anhidrat sa antiholinergijskim dejstvom
SI1881980T1 (sl) * 2005-05-02 2012-12-31 Boehringer Ingelheim International Gmbh Nove kristalinične oblike tiotropijevega bromida
KR101395881B1 (ko) * 2005-12-19 2014-05-21 시코르, 인크. 브롬화 티오트로피움의 신규한 형태 및 이의 제조 방법
WO2008102128A2 (en) * 2007-02-19 2008-08-28 Cipla Limited Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations

Also Published As

Publication number Publication date
JP2012507574A (ja) 2012-03-29
CN102238939B (zh) 2015-05-20
ZA201103347B (en) 2012-01-25
CA2742718A1 (en) 2010-05-14
MX2011004730A (es) 2011-05-30
RU2011122652A (ru) 2012-12-20
KR20110096538A (ko) 2011-08-30
AU2009312598A1 (en) 2010-05-14
WO2010052466A3 (en) 2010-11-04
EP2362766A2 (en) 2011-09-07
WO2010052466A2 (en) 2010-05-14
BRPI0916047A2 (pt) 2015-11-10
RU2565438C2 (ru) 2015-10-20
WO2010052466A8 (en) 2011-11-24
CN102238939A (zh) 2011-11-09

Similar Documents

Publication Publication Date Title
NZ592861A (en) Pharmaceutical aerosol composition
TWI660747B (zh) 溴化吡咯醣及福莫特羅組合之穩定加壓噴霧溶液組成物
EP3096737B1 (en) Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
AU2016234894B2 (en) Aerosol Formulation for COPD
JP2022037005A (ja) ５－アミノ－２，３－ジヒドロフタラジン－１，４－ジオンの結晶形
CN104918604A (zh) 药物组合物
EA201590179A1 (ru) Комбинированная терапия copd
JP2002522374A5 (xx)
JP2014528470A5 (xx)
JP2019528316A5 (xx)
JP2007524698A (ja) シクレソニドとグリコピロニウムとの組合せ物
WO2007135409A1 (en) Particulate drug and drug compositions and their uses
US20140363383A1 (en) Aerosol formulation for copd
KR20230038228A (ko) 글루코코르티코이드 절약제
RU2014104996A (ru) Способ получения дозирующего распыляющего ингалятора для лечения респираторного заболевания
US20070286815A1 (en) Medicinal Aerosol Formulations and Methods of Synthesizing Ingredients Therefor
NO332524B1 (no) Inhalerbar losningsformulering inneholdende et tiotropiumsalt, slike preparater for anvendelse som medikament samt anvendelse av slike for fremstilling av medikament for behandling av sykdom
CN104208690A (zh) 环索奈德、肾上腺素β2-受体激动剂分别包装并在一个吸入装置同时使用的药物组合物
CN104208688A (zh) 糠酸莫米松、肾上腺素β2-受体激动剂分别包装并在一个吸入装置同时使用的药物组合物
CN104208687A (zh) 不同活性成分分别包装并在一个吸入装置同时使用的干粉吸入药物组合物
CN104208689A (zh) 布地奈德、肾上腺素β2-受体激动剂分别包装并在一个吸入装置同时使用的药物组合物
CN104208686A (zh) 氟替卡松、肾上腺素β2-受体激动剂分别包装并在一个吸入装置同时使用的药物组合物
CN106667950A (zh) 一种药用胶囊材料
WO2005037245A3 (en) A multiple route medication for the treatment of rhinitis and asthma
TH127043B (th) ผลิตภัณฑ์รวมสำหรับบำบัด copd

Legal Events

Date Code Title Description
S883 Correction of error according to section 88(3) (mistake in register caused on part of patentee or applicant)

Free format text: CORRECTION TO INVENTOR (72)

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 04 NOV 2016 BY CPA GLOBAL

Effective date: 20130919

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 NOV 2017 BY CPA GLOBAL

Effective date: 20161105

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 NOV 2018 BY CPA GLOBAL

Effective date: 20180125

LAPS Patent lapsed